摘要
目的:探讨SRM-Ⅳ型BPPV诊疗系统复位治疗可疑性良性阵发性位置性眩晕患者的疗效。方法:选取我科眩晕门诊2016年9月~2016年11月经病史询问和SRM-Ⅳ型BPPV诊疗系统检测的132例可疑性BPPV患者作为研究对象,其中药物治疗组44例,给予止眩晕药物治疗;复位治疗组44例患者,单纯采用SRM-Ⅳ型BPPV诊疗系统进行复位治疗;复位治疗+药物组:在采用SRM-Ⅳ型BPPV诊疗系统复位治疗的基础上,加上止眩晕药物治疗,疗程14天,观察并统计患者的临床治疗效果。结果:药物治疗组44例患者中治愈18例,好转11例,无效15例,总有效率65.9%;复位治疗组44例患者中,治愈36例,好转5例,无效3例,总有效率93.2%。复位治疗+药物组中,治愈37例,好转3例,无效4例,总有效率90.9%。复位治疗或复位+药物治疗的治疗有效率高于单纯药物治疗(均P<0.01),复位治疗与药物+复位治疗治疗有效率之间的差别无统计学意义(P>0.01)。结论:对可疑性BPPV患者,复位治疗或复位+药物治疗的疗效优于于单纯药物治疗,复位治疗为其首选治疗方法。
Objective： To evaluate the efficacy of the particle repositioning maneuvers for the treatment of suspected benign paroxysmal positional vertigo （BPPV）. Methods： A total of 132 patients with suspected BPPV based on history or diagnostic tests, presented to our vertigo clinic between September 2016 and November 2016, were enrolled in the study. The patients were divided into 3 groups, 44 cases in each group, respectively receiving medical treatment, repositioning maneuver performed by a device （SRM-IV diagnostic and therapy system for BPPV） or medical treatment plus repositioning maneuver. The treatment efficacies among 3 groups were evaluated. Results： The effective rates were 65.9% in medical treatment group, 93.2% in repositioning maneuver group and 90.9% in medical treatment plus repositioning maneuver group, with a significant difference in effective rates between medical treatment group and repositioning maneuver group or repositioning maneuver plus medical treatment group （P〈0.01）, but no significant difference in effective rates between repositioning maneuver group and repositioning maneuver plus medical treatment group （P〉0.01）. Conclusion： Repositioning maneuver is a good choice for the treatment of suspected BPPV.
出处
《中国研究型医院》
2017年第1期15-18,共4页
Chinese Research Hospitals
